Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer as a Hidden Catalyst: Rethinking Postoperative Atrial Fibrillation After Cardiac Surgery.

Journal of clinical medicine·2026
Same author

Dose-response relationship between cell salvage volume, perioperative transfusion requirements, and postoperative clinical outcomes in cardiac surgery: A retrospective cohort study.

Journal of clinical anesthesia·2026
Same author

Optimizing Temperature in Ex Situ Heart Perfusion: A Comparative Review of Traditional and Novel Methods in Heart Transplantation.

Journal of cardiovascular development and disease·2026
Same author

First In-human study of a Novel Left Atrial Pressure Sensor: the Microtech LVAD Study.

Journal of cardiac failure·2025
Same author

Cardiac Surgery and Postoperative Atrial Fibrillation: The Role of Cancer.

Medicina (Kaunas, Lithuania)·2025
Same author

Is Total Arterial Grafting Superior to Multiarterial Grafting in Coronary Bypass?

The Thoracic and cardiovascular surgeon·2025

Related Experiment Video

Updated: Jun 12, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

Primary cardiac valve tumors.

Georgios P Georghiou1, Bernardo A Vidne, Gideon Sahar

  • 1Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, Petah Tiqwa and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. georgios_georghiou@cytanet.com.cy

Asian Cardiovascular & Thoracic Annals
|June 4, 2010
PubMed
Summary

Surgical treatment of primary cardiac valve tumors yielded excellent results for benign cases. However, malignant cardiac valve tumors carried a poor prognosis, with recurrence leading to death in some patients.

More Related Videos

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jun 12, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Oncology
  • Oncologic Pathology

Background:

  • Primary cardiac valve tumors are rare, presenting diverse clinical manifestations.
  • Surgical intervention is the primary treatment modality for symptomatic cardiac valve tumors.

Purpose of the Study:

  • To evaluate the surgical treatment outcomes for primary cardiac valve tumors.
  • To analyze the characteristics and prognosis of benign versus malignant cardiac valve tumors.

Main Methods:

  • Retrospective review of 7 patients (6 women, 1 man) aged 49-76 years treated between 1999 and 2006.
  • Analysis of clinical presentation, tumor characteristics (benign/malignant), surgical outcomes, and follow-up data.

Main Results:

  • Four tumors were benign, and 3 were malignant. All patients survived surgery with uneventful recovery.
  • Benign tumors had excellent early and midterm outcomes.
  • Malignant tumors had a poor prognosis, with 2 patients dying from recurrence despite no adjuvant therapy.

Conclusions:

  • Surgical resection offers excellent outcomes for benign cardiac valve tumors.
  • Malignant cardiac valve tumors present a significant challenge with a poor long-term prognosis.
  • Multidisciplinary management is crucial for optimizing outcomes in cardiac valve tumors.